Robert Peach
Direttore/Membro del Consiglio presso AMPLIA THERAPEUTICS LIMITED
Profilo
Dr. Robert J.
Peach is an Independent Non-Executive Director at AdAlta Ltd.
and an Independent Non-Executive Director at Amplia Therapeutics Ltd.
He is on the Board of Directors at AdAlta Ltd.
and Amplia Therapeutics Ltd.
Dr. Peach was previously employed as a Chief Scientific Officer by Receptos, Inc., a Vice President-Biology by Apoptos, Inc., a Senior Director-Oncology Discovery by Biogen Idec, Inc., and a Principal by Bristol Myers Squibb Co. He also served on the board at Avalia Immunotherapies Ltd.
He received his undergraduate degree from the University of Canterbury, a graduate degree from the University of Canterbury and a doctorate degree from the University of Otago.
Posizioni attive di Robert Peach
| Società | Posizione | Inizio |
|---|---|---|
| AMPLIA THERAPEUTICS LIMITED | Direttore/Membro del Consiglio | 02/09/2015 |
| ADALTA LIMITED | Direttore/Membro del Consiglio | 14/11/2016 |
Precedenti posizioni note di Robert Peach
| Società | Posizione | Fine |
|---|---|---|
| RECEPTOS INC | Fondatore | 27/08/2015 |
Apoptos, Inc.
 Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Apoptos, Inc. discovers and develops small molecule anticancer drugs. The company focuses in drug therapies that directly induce tumor cell apoptosis. It was founded in 2007 and is headquartered in San Diego, CA | Fondatore | 01/05/2009 |
| BIOGEN INC. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Avalia Immunotherapies Ltd.
 Avalia Immunotherapies Ltd. Medical/Nursing ServicesHealth Services Avalia Immunotherapies Ltd. develops immunotherapies that support the treatment of cancer. The company is headquartered in Lower Hutt, New Zealand. | Direttore/Membro del Consiglio | - |
Formazione di Robert Peach
| University of Canterbury | Graduate Degree |
| University of Otago | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| AMPLIA THERAPEUTICS LIMITED | Health Technology |
| ADALTA LIMITED | Health Technology |
| Aziende private | 3 |
|---|---|
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Receptos LLC engages in the provision of developing and commercializing of therapeutic candidates for the treatment of immune and inflammatory diseases. It offers Ozanimod for relapsing multiple sclerosis, Ozanimod for inflammatory bowel disease and RPC4046 for eosinophilic esophagitis. The company was founded by Marcus F. Boehm, Robert J. Peach, William H. Rastetter, Hugh Rosen and Raymond C. Stevens on September 26, 2008 and is headquartered in San Diego, CA. | Health Technology |
Apoptos, Inc.
Apoptos, Inc. Pharmaceuticals: MajorHealth Technology Apoptos, Inc. discovers and develops small molecule anticancer drugs. The company focuses in drug therapies that directly induce tumor cell apoptosis. It was founded in 2007 and is headquartered in San Diego, CA | Health Technology |
Avalia Immunotherapies Ltd.
Avalia Immunotherapies Ltd. Medical/Nursing ServicesHealth Services Avalia Immunotherapies Ltd. develops immunotherapies that support the treatment of cancer. The company is headquartered in Lower Hutt, New Zealand. | Health Services |
- Borsa valori
- Insiders
- Robert Peach
